Navigation Links
Gene-Expression Analysis of TP, DPD, and TS Using,,,the LightCycler mRNA Quantification KitsPLUS

In human cells, the enzymes thymidin phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), and thymidylate synthase (TS) play a pivotal role in the metabolism of pyrimidines. In cancer disease medical care, the cytotoxic compound 5-fluorouracil (5-FU) is the standard chemotherapy treatment for a wide range of solid tumors. Attempts to increase the efficacy and tolerability of fluoropyrimidine treatment has led to the development of Capecitabine (Xeloda), a fluoropyrimidine drug from Roche Pharmaceuticals. Capecitabine is not cytotoxic unless it is activated to 5-FU by TP a three-step mechanism. Therefore, it has several advantages over ordinary 5-FU by treatment [1, 2].



Capecitabine is preferentially activated and converted to 5-FU due to TP upregulation at the tumor site. 5-FU inhibits TS, an enzyme crucial for the de novo synthesis of thymidine nucleotides. The rate-limiting enzyme in the catabolism of 5-FU is DPD, which catalyzes the first step of pyrimidine degradation (Figure 1).

Efficacy and tolerability of Capecitabine or similar drugs may therefore largely depend on the expression rates of each of the three enzymes. These expression rates can be estimated by the detection of the relative mRNA expression levels of the three enzymes in tumor tissue or blood [3], using the new LightCycler TP, DPD, and TS mRNA Quantification KitsPLUS.

Materials and Methods

Fresh-frozen tissue and paraffin-embedded tissue (PET) slides (5 m) were taken from human xenografts in mouse models. Isolation of RNA was performed using the MagNA Lyser Instrument and the High Pure RNA Paraffin Kit. The human RNA panel was obtained from Clontech. Based on the LightCycler mRNA Quantification Kit concept, we have developed three new reagent kits for TP, DPD, and TS that are specially designed for usage with fresh-frozen tissues or PET in research applications. The kits are based on a two-step protocol for the quantification of target mRNA expression rates relative to a reference gene (glucose-6-phosphate dehydrogenase, G6PDH) using the LightCycler Instrument and the Relative Quantification Software.
In the first step (reverse transcription), gene-specific primers are utilized to obtain TP, DPD, TS, and G6PDH cDNA in separate reactions. Gene-specific priming is necessary as RNA from PET is degraded to fragments smaller than approximately 200 bp.
The cDNA is then used as a template for quantitative PCR using the LightCycler Hybridization Probe format. Additionally, calibrator RNA from an immortalized cell line is included in the kit and is used as an external standard to allow for relative quantification in each run.

Results and Applications

To validate the new kit concept we have performed three comparative studies:

Proof of principle specific priming

With the standard primer concentration (1 M), the amplification curves in cDNA synthesis tend to decline with decreasing template concentration (Figure 2). Reducing the concentration of the specific primers to 1/5 (0.2 M) leads to reproducible and stable curves in the reverse transcription- polymerase chain reaction (RT-PCR) dilution series, especially with low RNA concentrations (Figure 2). Template RNA in the range of 500 ng/l to as little as 32 pg/l was used. TP data are shown as being representative for DPD, TS, and G6PDH using calibrator RNA as a template.



The new primer concentration also extends the dynamic measuring range of the target and reference and improves sensitivity compared to random hexamer priming (Figure 3 a-c). Table 3d numerically shows the crossing point (Cp) ranges for all four genes TP, DPD, TS, and G6PDH.



The human RNA panel (healthy tissue)

We have also analyzed both priming concepts using a panel of 21 human RNA samples from healthy tissues. We observed a slight shift to smaller Cp values with specific priming for all four parameters TP, DPD, TS and G6PDH indicating the higher sensitivity of the new concept (Figure 4). These shifts depend on the parameter and the analyzed tissue type. Also, the comparison of the relative ratios reveals a tendency for slightly higher ratios with specific priming. This is caused by different Cp shifts between calibrator and sample RNA. Nevertheless, the expression rates are comparable and within a common range.



Comparison of fresh-frozen tissue vs. PET

For this study, we analyzed xenografts from human immortalized colon tumor cell lines HT29 and SW62 with the new kit concept. Total RNA was isolated from PET in 4 x 5-m slides and from matched fresh-frozen tissues in two 20-mg slices according to the High Pure RNA Paraffin Kit protocol. As depicted in Figure 5, the relative expression rates of TP, DPD, and TS are comparable in both tissue types.



The new kit concept with specific priming is superior to former hexamer protocols and shows comparable Cp values and ratios. The linear measuring ranges were extended and the sensitivity of analysis was improved for all three target genes, as well as for the reference gene G6PDH. The analysis of matched fresh-frozen tissues and PET yields nearly identical relative expression rates.

These preliminary and preclinical results suggest that the LightCycler Quantification KitsPLUS for TP, DPD and TS are well suited for the analysis of fresh-frozen tissue samples, as well as for retrospective investigations with PET samples in research applications.


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. The Flexible matriXarray Chip System: A New Perspective for Probe Optimization in Gene-Expression Profiling
2. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
3. Epitope-Tagging Vectors for Functional Analysis in Yeast
4. Map and Link Human Genetic Disorders with SSLP Analysis
5. CastAway Precast Gels for Rapid Automated DNA Sequence Analysis
6. Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf cMaster RTplusPCR System
7. Structural Analysis of Glycosylated Peptides in Complex Mixtures with Ion Trap MSn
8. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
9. Increased Sensitivity in Microarray Analysis
10. Agilent 2100 Bioanalyzer Automated Analysis System
11. Analysis of Microarray Data
Post Your Comments:
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... and commercializes proprietary technologies and products for advanced microarray ... approved for trading in the United States ... expected to commence on September 17, 2014 on the ... to trade on the TSX Venture Exchange under its ...
(Date:9/17/2014)... 17 de septiembre de 2014  Cryoport, ... proveedor mundial de soluciones logísticas avanzadas criogénicas ... la vida, anunció hoy la contratación de ... con sede en Rótterdam, Países Bajos, para ... Europa en rápido crecimiento. Según los términos ...
(Date:9/17/2014)... , September 17, 2014 ... mode of action from a truly novel ... MGB Biopharma, a biopharmaceutical company ... announces today that it has secured £4.0m ... lead antibacterial, MGB-BP-3, against a range of ...
(Date:9/17/2014)... Cambridge, MA (PRWEB) September 17, 2014 ... and Safety (ACRES) , a multi-stakeholder non-profit collaborative ... and efficiency in clinical research, today announced Phase ... (SASI). , Amir H. Kalali, ... Quintiles and Arti Bajpai, President, Compliance and Quality ...
Breaking Biology Technology:SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7Global Standards Initiative for Clinical Research Sites Advances 2Global Standards Initiative for Clinical Research Sites Advances 3Global Standards Initiative for Clinical Research Sites Advances 4
... April 30 Dendreon Corporation,(Nasdaq: DNDN ) today announced ... Deutsche Bank 33rd Annual Health Care Conference ... ET, Bank of America Health Care Conference Four ... 11:00 a.m. ET, Rodman & Renshaw 5th Annual Global ...
... 3rd Among US For-Profit Healthcare Companies, EL ... provider of kidney care services, announced it has ... Magazine as one of the Top 125,ranking companies ... awarded to organizations that demonstrate a deep,commitment to ...
... Molecular Quantitative Viral Load Assay, ORANGE COUNTY, ... BEC ) announced today that it has ... virus (HCV) from Siemens Healthcare,Diagnostics. Under the agreement, ... viral load HCV blood test for use on ...
Cached Biology Technology:DaVita Honored for 4th Year as Training Top 125 Recipient 2Beckman Coulter Acquires Rights to Hepatitis C Virus 2
(Date:9/17/2014)... EC-FP5 four-year project, delivering its first release in 2004. ... in several EC projects, as a part of the ... BON), to increase the general awareness of the work ... dissemination of the Fauna Europaea results, the ... e-Publishing tools to prepare data papers for all 56 ...
(Date:9/17/2014)... very cleverly, some lessons on how to create the ... Shaw, director of the Optical Technology Center at Montana ... the nanoscale, we,ll discover them." , Some of those ... a conference called "The Nature of Light: Light in ... University of Arizona College of Optical Sciences. The conference ...
(Date:9/17/2014)... research from the Copenhagen Centre for Social Evolution and ... theory that birth weight and -length can partially predict ... such as autism and schizophrenia later in life. The ... and subsequent hospital diagnoses for up to 30 years, ... The study is published today in the Proceedings ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3
... Ants, wasps and humans live in highly complex societies. Our ... trying to find the balance between cooperation and conflict. Understanding ... us key insights into the evolution of sociality in animals. ... biologist Floria Mora-Kepfer Uy, looks at colonies of social wasps ...
... , Press conference announcement: Three years after Fukushima: ... dial-in information, Press room information, Attention PIOs: Sending ... information, Press registration information, Hotel information, U.S. visa ... information about the Ocean Sciences Meeting, please see ...
... powered by methanol or hydrogen have been well studied, ... biomass as a fuel because of the lack of ... researchers at the Georgia Institute of Technology have developed ... converts biomass to electricity with assistance from a catalyst ...
Cached Biology News:What cooperation and conflict in an insect's society can teach us about social acceptance 22014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 22014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 32014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 42014 Ocean Sciences Meeting: Press conference announcement; sending press kits; press registration 5Solar-induced hybrid fuel cell produces electricity directly from biomass 2Solar-induced hybrid fuel cell produces electricity directly from biomass 3
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
...
Sheep polyclonal to Quinolone ( Abpromise for all tested applications). Antigen: Norfloxacin(N)conjugated to BSA...
Certified U.S. origin. Bovine Serum:, *Certified U.S. origin. Available raw, nonsterile filtered, or sterile filtered. , , *Sterility tested , , *Low Hemoglobin levels , , *Mycoplasma testing upon...
Biology Products: